Q2 2024 |
49 |
$2.14B |
+$258M |
-$322M |
-$64M |
NAMS, MIRM, KRYS, HLVX, PHAT
|
13F-HR |
8/15/2024, 12:49 PM |
Q1 2024 |
50 |
$2.37B |
+$230M |
-$107M |
+$123M |
NAMS, KRYS, MIRM, HLVX, ALPN
|
13F-HR |
5/15/2024, 12:00 PM |
Q4 2023 |
49 |
$1.87B |
+$156M |
-$85M |
+$70.6M |
MIRM, HLVX, NAMS, KRYS, BBIO
|
13F-HR |
2/14/2024, 01:55 PM |
Q3 2023 |
51 |
$1.5B |
+$238M |
-$250M |
-$11.7M |
MIRM, HLVX, KRYS, NAMS, PHAT
|
13F-HR |
11/14/2023, 01:40 PM |
Q2 2023 |
48 |
$1.67B |
+$153M |
-$80.1M |
+$72.6M |
HLVX, KDNY, PHAT, NAMS, KRYS
|
13F-HR |
8/14/2023, 09:48 AM |
Q1 2023 |
49 |
$1.38B |
+$109M |
-$171M |
-$62.1M |
HLVX, NAMS, KDNY, ARQT, MIRM
|
13F-HR |
5/15/2023, 12:41 PM |
Q4 2022 |
44 |
$1.61B |
+$227M |
-$39.6M |
+$188M |
HLVX, IMGO, ARQT, KDNY, NAMS
|
Restatement |
2/7/2023, 02:30 PM |
Q3 2022 |
43 |
$1.27B |
+$201M |
-$74.6M |
+$127M |
HLVX, ARQT, PHAT, KDNY, SNDX
|
13F-HR |
11/14/2022, 10:29 AM |
Q2 2022 |
41 |
$1.04B |
+$148M |
-$179M |
-$30.5M |
ARQT, HLVX, KRYS, MIRM, KDNY
|
13F-HR |
8/10/2022, 03:07 PM |
Q1 2022 |
42 |
$1.17B |
$0 |
$0 |
|
ARQT, PHAT, MIRM, SRRA, KRYS
|
13F-HR |
5/13/2022, 07:15 PM |